We recently found that Otub1 prevents K48-linked ubiquitin conjugates from c-Maf as its deubiquitinase and inhibition of Otub1 leads to c-Maf degradation and MM cell apoptosis18, suggesting the Otub1/c-Maf axis is a potential target for MM treatment. This evidence concerns the gene MAF and Miyoshi myopathy.